News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
798,130 Results
Type
Article (74337)
Company Profile (433)
Press Release (723360)
Multimedia
Podcasts (107)
Webinars (14)
Section
Business (222742)
Career Advice (3022)
Deals (38379)
Drug Delivery (124)
Drug Development (88631)
Employer Resources (186)
FDA (17740)
Job Trends (16403)
News (379520)
Policy (37599)
Tag
Academia (2973)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (55112)
ALS (99)
Alzheimer's disease (1501)
Antibody-drug conjugate (ADC) (150)
Approvals (17704)
Artificial intelligence (294)
Autoimmune disease (28)
Automation (16)
Bankruptcy (393)
Best Places to Work (12367)
BIOSECURE Act (22)
Biosimilars (118)
Biotechnology (296)
Bladder cancer (85)
Brain cancer (31)
Breast cancer (299)
Cancer (2422)
Cardiovascular disease (204)
Career advice (2542)
Career pathing (33)
CAR-T (171)
Cell therapy (480)
Cervical cancer (21)
Clinical research (71484)
Collaboration (906)
Company closure (1)
Compensation (552)
Complete response letters (30)
COVID-19 (2861)
CRISPR (48)
C-suite (263)
Cystic fibrosis (107)
Data (2263)
Decentralized trials (2)
Denatured (32)
Depression (55)
Diabetes (297)
Diagnostics (6825)
Digital health (20)
Diversity (8)
Diversity, equity & inclusion (46)
Drug discovery (137)
Drug pricing (125)
Drug shortages (31)
Duchenne muscular dystrophy (101)
Earnings (91626)
Editorial (45)
Employer branding (23)
Employer resources (160)
Events (123873)
Executive appointments (770)
FDA (19060)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (805)
Gene editing (119)
Generative AI (25)
Gene therapy (353)
GLP-1 (850)
Government (4965)
Grass and pollen (6)
Guidances (67)
Healthcare (20422)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (146)
Indications (30)
Infectious disease (3021)
Inflammatory bowel disease (153)
Inflation Reduction Act (9)
Influenza (55)
Intellectual property (101)
Interviews (556)
IPO (17438)
IRA (48)
Job creations (4496)
Job search strategy (2124)
Kidney cancer (11)
Labor market (38)
Layoffs (545)
Leadership (23)
Legal (9398)
Liver cancer (81)
Lung cancer (344)
Lymphoma (158)
Machine learning (7)
Management (63)
Manufacturing (342)
MASH (75)
Medical device (14335)
Medtech (14340)
Mergers & acquisitions (21491)
Metabolic disorders (787)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (113)
Neuropsychiatric disorders (34)
Neuroscience (2105)
NextGen: Class of 2025 (7294)
Non-profit (5015)
Now hiring (40)
Obesity (425)
Opinion (261)
Ovarian cancer (78)
Pain (99)
Pancreatic cancer (86)
Parkinson's disease (161)
Partnered (22)
Patents (249)
Patient recruitment (115)
Peanut (51)
People (63094)
Pharmaceutical (93)
Pharmacy benefit managers (21)
Phase I (22136)
Phase II (31166)
Phase III (23453)
Pipeline (1254)
Policy (169)
Postmarket research (3257)
Preclinical (9906)
Press Release (72)
Prostate cancer (113)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (430)
Real estate (6906)
Recruiting (72)
Regulatory (25539)
Reports (48)
Research institute (2643)
Resumes & cover letters (482)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (141)
Series B (89)
Service/supplier (21)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4068)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (46)
The Weekly (73)
Vaccines (807)
Venture capitalists (44)
Weight loss (302)
Women's health (38)
Worklife (20)
Date
Today (4)
Last 7 days (942)
Last 30 days (2686)
Last 365 days (34752)
2025 (11527)
2024 (37432)
2023 (42274)
2022 (53659)
2021 (58387)
2020 (57172)
2019 (50406)
2018 (38238)
2017 (35982)
2016 (36635)
2015 (42744)
2014 (37292)
2013 (33438)
2012 (35214)
2011 (35440)
2010 (34486)
Location
Africa (1056)
Alabama (58)
Alaska (7)
Arizona (257)
Arkansas (13)
Asia (46052)
Australia (7933)
California (6386)
Canada (2057)
China (559)
Colorado (280)
Connecticut (300)
Delaware (156)
Europe (105455)
Florida (940)
Georgia (220)
Hawaii (1)
Idaho (62)
Illinois (598)
India (28)
Indiana (328)
Iowa (11)
Japan (168)
Kansas (109)
Kentucky (27)
Louisiana (12)
Maine (70)
Maryland (954)
Massachusetts (4842)
Michigan (232)
Minnesota (414)
Mississippi (2)
Missouri (90)
Montana (31)
Nebraska (26)
Nevada (64)
New Hampshire (68)
New Jersey (1809)
New Mexico (31)
New York (1821)
North Carolina (1104)
North Dakota (9)
Northern California (2747)
Ohio (215)
Oklahoma (14)
Oregon (40)
Pennsylvania (1415)
Puerto Rico (13)
Rhode Island (33)
South America (1450)
South Carolina (24)
South Dakota (1)
Southern California (2381)
Tennessee (104)
Texas (941)
United States (24395)
Utah (189)
Virginia (160)
Washington D.C. (70)
Washington State (583)
West Virginia (3)
Wisconsin (67)
798,130 Results for "huntingdon s disease research group chdi foundation inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease
Evotec SE has announced the extension of its 20-year collaboration with CHDI Foundation, Inc. CHDI is a privately funded nonprofit biomedical research organisation exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of those affected by Huntington’s disease.
May 28, 2024
·
5 min read
BioMidwest
Geneoscopy to Present Research on Inflammatory Bowel Disease at Crohn’s & Colitis Foundation’s IBD Innovate 2024 Conference
Geneoscopy, Inc. will present research at the Crohn’s & Colitis Foundation’s IBD Innovate 2024 Conference in Cambridge, Mass., April 9-10.
April 3, 2024
·
2 min read
Press Releases
NeuroDex Inc. Receives Grant from The Michael J. Fox Foundation to Advance Biomarker Research for Parkinson’s Disease
November 13, 2024
·
1 min read
Rare diseases
How SpringWorks Took Pfizer’s Rare Disease Ghost Drug and Got It to Patients
SpringWorks Therapeutics sprung out of Pfizer’s storeroom, when a rare disease advocacy group pushed to keep a program for neurofibromatosis alive. This method could work for “every rare disease under the sun,” advocates say.
February 26, 2025
·
5 min read
·
Annalee Armstrong
Sponsored
SignalChem’s Tau Proteins: Accelerating Neurodegenerative Disease Research
SignalChem Biotech provides diverse recombinant Tau proteins for research, helping advance tau-targeted therapies that may modify disease progression in Alzheimer’s and related tauopathies.
November 18, 2024
·
3 min read
Genetown
Analysis Group Researchers Coauthor First Study Revealing Age-Specific Incidence of Pneumococcal Disease in Young Children
Researchers from Analysis Group, a global leader in health economics and outcomes research (HEOR), have coauthored the first large-scale US study of how pneumococcal disease (PD) manifests by age group, insurance status, and sociodemographic characteristics in young children aged 0–2 years during the study period (1998–2019).
June 6, 2024
·
2 min read
Business
MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance Parkinson’s Research
MilliporeSigma and The Michael J. Fox Foundation for Parkinson’s Research (MJFF), are advancing research aimed at slowing progression of Parkinson’s disease (PD).
June 18, 2024
·
4 min read
Press Releases
The Michael J. Fox Foundation Expands Landmark Parkinson’s Research Study toward Better Treatments and Prevention
April 30, 2025
·
10 min read
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension)
April 25, 2025
·
3 min read
Pharm Country
Kannalife Secures Funding of $1.49 Million from The Michael J. Fox Foundation for Parkinson’s Research
Kannalife Sciences, Inc. is pleased to announce it has been awarded funding of $1,493,409 million from The Michael J. Fox Foundation for Parkinson’s Research.
June 25, 2024
·
4 min read
1 of 79,813
Next
